Press Releases

First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach BELLINGHAM, Wash., Oct. 08, 2025 (GLOBE NEWSWIRE) — eXp Realty®, the largest independent real estate brokerage in the world and a core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), has announced the launch of eXp UK Commercial, expanding the company’s commercial real estate capabilities in one of Europe’s most dynamic property markets. With this launch, eXp becomes the first agent-powered platform in the UK to offer both residential and commercial services under a single model, part of a broader global strategy to empower self-employed agents with access to tools, training, and opportunities across the full property spectrum. It also builds on eXp UK’s rapid growth in the residential sector, where its self-employed model has already reshaped the estate agency landscape. “The UK commercial property sector has grown substantially. It’s a $10 billion opportunity hiding in plain sight,” said Adam Day, International Expansion Leader for Europe. “Traditional commercial models have kept too many agents from benefiting fully with the freedom, earnings potential, and flexibility to serve clients across all markets, but we’re changing that. Plus with the backing of our global community, agents can now maximise interest in UK commercial property on a global scale, not just a domestic one.” The UK commercial real estate industry is forecast to reach £8.1 billion ($10.2 billion USD) in revenue in 2025, following decade-long growth of more than 50% (IBISWorld). Yet the sector remains dominated by traditional firms, creating a clear gap for agents seeking greater autonomy, earning power, and a

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by The Column Group (TCG), DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments. Coinciding with its launch, Nilo announced the appointment of Kim Seth, Ph.D., as Chief Executive Officer and Board director. Founded by world-leading scientists Charles Zuker, Ph.D. (Columbia University), Ruslan Medzhitov, Ph.D. (Yale University), and Steve Liberles, Ph.D. (Harvard University), Nilo was created in collaboration with TCG to translate groundbreaking scientific insights in neuro-immunology into new therapeutic strategies. Dr. Seth joins Chief Scientific Officer Laurens Kruidenier, Ph.D., in leading the company’s transition from stealth into its next stage of growth. The financing fuels the establishment of Nilo’s laboratories in New York City, growth of its interdisciplinary research and development team, and advancement of the company’s preclinical programs. Nilo is developing drugs that harness neural circuits to restore immune homeostasis centrally, offering a differentiated approach to immunomodulation and moving beyond conventional immunosuppression. The company builds on seminal scientific discoveries from the laboratory of Charles Zuker, Ph.D. (Columbia University Principal Investigator and Howard Hughes Medical Institute Investigator), which identified specific vagal neurons that regulate systemic immune activation and inflammation. By targeting these central “master regulator” brain-body circuits, Nilo is employing its novel therapeutic approach to modulate multiple immune pathways in concert, reducing the risk of therapeutic resistance and broadening potential impact across a wide spectrum of autoimmune and inflammatory diseases with large unmet need. Dr. Seth brings over 25 years of biopharma industry experience, with operating roles across multiple

BERLIN, GERMANY – Newsaktuell – 29 September 2025 – The Regional Court of Frankfurt am Main has granted a comprehensive preliminary injunction in favor of Josip Heit, strategic advisor to Apertum Holding a company specialized in technology solutions, against the Ireland-based website “BE Conflict Management” and its domain bekm.eu, which had published a series of defamatory statements in both English and German concerning Mr. Heit, Apertum Holding, and others. In its ruling dated September 19, 2025, (Case No. 2-03 O 315/25), the Regional Court found that 14 statements made by the website were unlawful and in violation of press law principles. These statements were ordered removed, and any future publication could result in penalties of up to EUR 250,000- or six-months’ imprisonment. The injunction follows a prior legal success in the United States, where the Texas State Securities Board rescinded its cease-and-desist order against Apertum Holding and Mr. Heit in the face of robust legal defense from Apertum Holding and Mr. Heit, confirming that no enforcement action was warranted. Nevertheless, BE Conflict Management continued to disseminate misleading reports based on now-dismissed claims. The Frankfurt Regional Court’s ruling underscores that republishing allegations without verifying current legal status or offering the affected parties a right to respond contravenes journalistic standards and German media law. “This injunction is a significant step in protecting our clients’ reputation,” said attorney Christian-Oliver Moser, founding partner of the Berlin-based law firm IRLE MOSER, which specializes in media law and represents Apertum Holding and Mr. Heit. “We’ve long fought against anonymous online smear campaigns masquerading as investigative journalism. This decision reaffirms the rule-of-law protections available in Germany against such tactics.” Josip Heit, strategic advisor to Apertum Holding, added: “We welcome the court’s clear statement: unfounded accusations have no place in public discourse. We remain fully committed to legal

منطقة هونج كونج الإدارية الخاصة – Media OutReach Newswire – 1أكتوبر 2025 – وقّعت كلا من شركة منتجات الألومنيوم ألوبكو (ALUPCO) وهي مُنتِج رائد لقطاعات الألومنيوم في المملكة العربية السعودية، ومجموعة الألومنيوم الآسيوية إيه إيه جي (AAG) إحدى كبرى شركات تصنيع الألومنيوم في هونج كونج ذات القاعدة الإنتاجية في البر الصيني الرئيسي اتفاقية في 29 سبتمبر بهونج كونج. وتنص الشراكة على تأسيس ثلاث مشاريع مشتركة، تشمل شركتين عضويتين في إيه إيه جي هما ألوهاوس (AluHouse ) وماك ميتال (MacMetal). وباستثمارات تصل إلى 500 مليون دولار أمريكي، ستُشيّد الشركتان أكبر قاعدة صناعية متكاملة لتصنيع الألومنيوم التحويلي في المملكة العربية السعودية، مع التركيز على قطاعات قولبة الألومنيوم، والمساكن المعيارية، وهياكل الألواح الشمسية. وقد وقّع الاتفاقية السيد خالد عبد المنعم (Khaled Abdel-Moneim)، الرئيس التنفيذي لشركة ألوبكو (في المقدمة يمينًا)، والسيد إيريك كوونغ (Eric Kwong)، نائب رئيس مجموعة إيه إيه جي ورئيس شركة آلو هاوس (في المقدمة يسارًا). ومن بين الضيوف الشاهدين على التوقيع (خلفهما من اليمين إلى اليسار) السيد عبد اللطيف المبارك (Abdellateif Al Mubarak) رئيس مجلس إدارة ألوبكو، والسيد محمود الأسمري (Mahmoud Al-Asmari) مدير قطاع المعادن والفلزات في المركز الوطني للتنمية الصناعية (NIDC) في المملكة العربية السعودية، والسيد نيكولاس هو ليك تشي (Nicholas Ho Lik Chi) مفوض مبادرة الحزام والطريق في منطقة هونج كونج الإدارية الخاصة؛ والسيد كوونغ رئيس مجلس إدارة مجموعة إيه إيه جي، والسيد هنري كوونغ نائب الرئيس الأول في مجموعة إيه إيه جي. وشهد حفل التوقيع في هونج كونج كبار ممثلي حكومتي منطقة هونج كونج الإدارية الخاصة والمملكة العربية السعودية، من بينهم قاضي الصلح إيريكي لاو تشون كيت (Ir Ricky Lau Chun-kit) الأمين الدائم للتنمية (الأشغال)، والسيد نيكولاس هو ليك-تشي مفوض مبادرة الحزام والطريق في منطقة هونج كونج الإدارية الخاصة، والسيد محمود الأسمري مدير قطاع المعادن والفلزات في المركز الوطني للتنمية الصناعية في المملكة العربية السعودية، إلى جانب عدد من أبرز قادة القطاع. صرح محمود الأسمري، مدير قطاع المعادن في